Baker will assume the role at the end of the fiscal year following the planned retirement of Scott Aakre AUSTIN, Minn. , May 16, 2025 /PRNewswire/ -- Hormel Foods Corporation (NYSE: HRL), a Fortune 500 global branded food company, announced that Jeff Baker, group vice president of Retail marketing for Value-Added Meats, will assume the role of group vice president for Retail marketing at the end of the company's fiscal 2025.

image for news Jeff Baker Named Group Vice President for Retail Marketing at Hormel Foods

Hello Group to Report First Quarter 2025 Results on June 5, 2025 — Neutral

MOMO   PRNewsWire — May 16, 2025

BEIJING , May 16, 2025 /PRNewswire/ -- Hello Group Inc. (NASDAQ: MOMO) (the "Company"), a leading player in mainland China's online social networking space, today announced that it will release its unaudited financial results for the first quarter ended March 31, 2025 before U.S. markets open on Thursday, June 5, 2025. Hello Group's management will host an earnings conference call on Thursday, June 5, 2025, at 8:00 a.m.

image for news Hello Group to Report First Quarter 2025 Results on June 5, 2025

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=148777&wire=1&utm_campaign=10 or contact Joseph E. Levi, Esq.

image for news Contact Levi & Korsinsky by June 16, 2025 to Join Class Action Against Zenas BioPharma, Inc. (ZBIO)

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=148776&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Urges Civitas Resources (CIVI) Shareholders to Act Before Lead Plaintiff Deadline July 1, 2025

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced today the early tender results for its tender offers to purchase for cash certain of its outstanding series of Notes. IFF also announced it has increased the previously announced Pool 1 Maximum Amount (as defined below) from $1,000,000,000 to $1,100,000,000 (the “Amended Pool 1 Maximum Amount”), the Pool 2 Maximum Amount (as defined below) from $800,000,000 to $900,000,000 (the “Amended Pool 2 Maximum Amount”, and together with the Amended Po.

image for news IFF Announces Early Tender Results and Increase of Tender Offers for Certain Outstanding Series of Notes

Microsoft offered to unbundle its Office 365 and Microsoft 365 software suites from its Teams workplace communication app to address competition concerns from European regulators.

image for news Microsoft offers to sell Office without Teams to placate EU regulators

JD Sports Fashion PLC (LSE:JD.) could become a target for a take-private deal, according to a note from Citi, which highlights how depressed valuations and favourable financial mechanics could make a buyout feasible and potentially lucrative.

image for news Could JD Sports go private? Leading investment bank raises the possibility after Foot Locker bid

SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Zenas BioPharma, Inc. (NASDAQ: ZBIO) securities pursuant and/or traceable to Zenas BioPharma's registration statement issued in connection with Zenas BioPharma's initial public offering (the “IPO”) held on or around September 13, 2024, and were damaged thereby, have until June 16, 2025 to seek appointment as lead plaintiff of the Zenas BioPharma class action lawsuit. Captioned Buathongsri v. Zenas BioPharma, Inc., No. 25-cv-10988 (D. Mass.), the Zenas BioPharma class action lawsuit charges Zenas BioPharma as well as certain of Zenas BioPharma's …

image for news ZBIO INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Zenas BioPharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=148775&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Urges Compass Diversified (CODI) Shareholders to Act Before Lead Plaintiff Deadline July 8, 2025

LONDON & DENVER & JOHANNESBURG--(BUSINESS WIRE)--AngloGold Ashanti plc (the “Company”) (NYSE: AU; JSE: ANG) announces that an Executive Director, Gillian Doran, and Executive Officers of the Company, Terry Briggs and Marcelo Godoy, have dealt in securities of the Company. A portion of the respective shares received have been sold to satisfy related taxes as detailed below. Name of Executive Director Gillian Doran Name of Company AngloGold Ashanti plc Date of transaction 15 May 2025 Nature of tr.

image for news Dealings in Securities by an Executive Director and Executive Officers of AngloGold Ashanti plc

UnitedHealth Group investors, stunned by missteps at the once predictable healthcare giant, are warily expecting strategic changes in its Medicare Advantage health insurance business over the next year.

image for news UnitedHealth investors wary and looking for Medicare strategic change

NEW YORK, NY / ACCESSWIRE / May 16, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against The Bancorp, Inc. (NASDAQ:TBBK) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Bancorp, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/the-bancorp-inc.

image for news TBBK LAST CALL: The Bancorp, Inc. Class Action Deadline is Today, May 16 - Contact BFA Law

JAAA: Underperformance Corrected, Warning Stays — Neutral

JAAA   Seeking Alpha — May 16, 2025

Janus Henderson AAA CLO ETF has experienced an unusual year, marked by significant market fluctuations and investor sentiment shifts. The ETF's performance has been influenced by macroeconomic factors, including interest rate changes and credit market conditions. There has been a lot of commentary on "widening credit spreads." Despite volatility, JAAA's high-quality collateralized loan obligations offer a compelling risk-reward profile for long-term investors, especially if.

image for news JAAA: Underperformance Corrected, Warning Stays

Alexa, where are your users?

image for news Focus: Weeks after Amazon's Alexa+ AI launch, a mystery: where are the users?

Boeing appears to be making a longer-term low. The company has been hounded by bad news, falling since 2019 and giving back 78.6% of its ten-year 2009-2019 bull market.

image for news Dow Jones: Buy Boeing And United Health Is Headed to A September Low

ArcelorMittal Is Losing The Margin War–Here's Why — Negative

MT   Forbes — May 16, 2025

ArcelorMittal (NYSE:MT) stock has been on a roll, increasing over 16% in just the last month after posting better-than-expected results for Q1 of 2025 and a positive outlook for the year. However, despite the recent optimism, there's one key problem that might catch investors off guard.

image for news ArcelorMittal Is Losing The Margin War–Here's Why

The U.S. defense contractor is trying to expand its production and supply chains in Europe, a senior executive said.

image for news Lockheed Martin Speeds Up European Defense Tie-Up Talks Amid EU Push to Buy Local

Haploinsufficient SYNGAP1 mice treated with CMP-SYNGAP-01 demonstrated an increase in SYNGAP1 protein levels; treatment rescued multiple SYNGAP1-dependent behavioral phenotypes

image for news CAMP4 Presents Translational Data from SYNGAP1-Related Disorders Program Showcasing Increased Protein in Non-Human Primates and Reviews Preclinical and Detailed Single Ascending Dose Safety Data from Urea Cycle Disorders Program at the 28th American Society of Gene and Cell Therapy Annual Meeting

SAN DIEGO, May 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Compass Diversified Holdings (NYSE: CODI) publicly traded securities between May 1, 2024 and May 7, 2025, both dates inclusive (the “Class Period”), have until July 8, 2025 to seek appointment as lead plaintiff of the Compass Diversified class action lawsuit. Captioned Augenbaum v. Compass Diversified Holdings, No. 25-cv-01003 (C.D. Cal.), the Compass Diversified class action lawsuit charges Compass Diversified Holdings, Compass Group Diversified Holdings LLC, Compass Group Management LLC, and certain of Compass Diversified's top current …

image for news CODI INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Compass Diversified Holdings and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

NEW YORK--(BUSINESS WIRE)--OS Therapies Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology company, today reported first quarter 2025 financial results ended March 31, 2025 and provided a business update. “The first quarter of 2025 was a crucial execution quarter for OS Therapies, as we announced positive data from our OST-HER2 Phase 2b clinical trial in the prevention of recurrent, fully resected, lung metastat.

image for news OS Therapies Reports First Quarter 2025 Financial Results and Provides Business Update